Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 7, 2007 - Issue 6
Submit an article Journal homepage
404
Views
42
CrossRef citations to date
0
Altmetric
Review

Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease

James K Sheffield Department of Neurology, Baylor College of Medicine, Parkinson’s Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. [email protected]
&
Joseph Jankovic Professor of Neurology, Director of Parkinson’s Disease Center & Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Parkinson’s Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. [email protected]
Pages 637-647 | Published online: 10 Jan 2014

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Frank J Lebeda, Regina Z Cer, Robert M Stephens & Uma Mudunuri. (2010) Temporal characteristics of botulinum neurotoxin therapy. Expert Review of Neurotherapeutics 10:1, pages 93-103.
Read now
Heinz Reichmann & Tjalf Ziemssen. (2009) Treatment strategies for nonmotor manifestations of Parkinson's disease. Expert Opinion on Pharmacotherapy 10:5, pages 773-784.
Read now

Articles from other publishers (40)

Bahman JabbariBahman Jabbari. 2022. Botulinum Toxin Treatment of Pain Disorders. Botulinum Toxin Treatment of Pain Disorders 235 253 .
Veronica Antipova, Carsten Holzmann, Alexander Hawlitschka, Martin Witt & Andreas Wree. (2021) Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease. Toxins 13:7, pages 505.
Crossref
Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl & Pierre Burbaud. (2019) Dystonia and dopamine: From phenomenology to pathophysiology. Progress in Neurobiology 182, pages 101678.
Crossref
Angeline Jocson & Mark Lew. (2019) Use of botulinum toxin in Parkinson's disease. Parkinsonism & Related Disorders 59, pages 57-64.
Crossref
Nicki Niemann & Joseph Jankovic. (2018) Botulinum Toxin for the Treatment of Hand Tremor. Toxins 10:7, pages 299.
Crossref
Francisco Cardoso. (2018) Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections. Toxicon 147, pages 107-110.
Crossref
Veronica Bruno, Maria Eliza Freitas, Deborah Mancini, Jane P. Lui, Janis Miyasaki & Susan H. Fox. (2017) Botulinum Toxin Type A for Pain in Advanced Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:1, pages 23-29.
Crossref
Parul Jindal & Joseph Jankovic. 2018. Botulinum Toxin Treatment in Clinical Medicine. Botulinum Toxin Treatment in Clinical Medicine 23 48 .
Bruno Ella, Imad Ghorayeb, Pierre Burbaud & Dominique Guehl. (2017) Bruxism in Movement Disorders: A Comprehensive Review. Journal of Prosthodontics 26:7, pages 599-605.
Crossref
Veronica A. Bruno, Susan H. Fox, Deborah Mancini & Janis M. Miyasaki. (2016) Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43:5, pages 697-702.
Crossref
Hyung-Eun Park, Ji-Eun Lee, Byung-chul Son & Joong-Seok Kim. (2016) Rabbit syndrome associated with medullary compression by vertebral artery. Neurological Sciences 37:7, pages 1167-1168.
Crossref
Yair Zlotnik, Yacov Balash, Amos D. Korczyn, Nir Giladi & Tanya Gurevich. (2015) Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes. Parkinson's Disease 2015, pages 1-6.
Crossref
John D. Salamone, Samantha Podurgiel, Lyndsey E. Collins-Praino & Mercè Correa. 2015. Movement Disorders. Movement Disorders 631 640 .
Reversa Mills, Laxman Bahroo & Fernando Pagan. (2014) An Update on the Use of Botulinum Toxin Therapy in Parkinson’s Disease. Current Neurology and Neuroscience Reports 15:1.
Crossref
Meir Plotnik, Shirley Shema, Moran Dorfman, Eran Gazit, Marina Brozgol, Nir Giladi & Jeffrey M. Hausdorff. (2014) A motor learning-based intervention to ameliorate freezing of gait in subjects with Parkinson’s disease. Journal of Neurology 261:7, pages 1329-1339.
Crossref
S.J. Podurgiel, E.J. Nunes, S.E. Yohn, J. Barber, A. Thompson, M. Milligan, C.A. Lee, L. López-Cruz, M. Pardo, O. Valverde, C. Lendent, Y. Baqi, C.E. Müller, M. Correa & J.D. Salamone. (2013) The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: Implications for pharmacological models of parkinsonian tremor. Neuroscience 250, pages 507-519.
Crossref
Joseph JankovicMark Stacy. 2013. Parkinson’s Disease: Medical and Surgical Treatment. Parkinson’s Disease: Medical and Surgical Treatment 61 78 .
Fariborz Rahimi, Carina Bee, Derek Debicki, Angela C. Roberts, Priya Bapat & Mandar Jog. (2014) Effectiveness of BoNT A in Parkinson's Disease Upper Limb Tremor Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:5, pages 663-669.
Crossref
Burcu Altunrende, Serpil Yildiz, Basak Kandi & Nebil Yildiz. (2013) Sympathetic skin responses from the scalp evoked by electrical stimulation in seborrheic dermatitis. The Journal of Dermatology 40:6, pages 458-462.
Crossref
Barry Rawicki. 2013. Rehabilitation in Movement Disorders. Rehabilitation in Movement Disorders 44 54 .
. 2013. Rehabilitation in Movement Disorders. Rehabilitation in Movement Disorders 25 54 .
Saedeh Dadgar, Zack Ramjan & Wely B. Floriano. (2013) Paclitaxel Is an Inhibitor and Its Boron Dipyrromethene Derivative Is a Fluorescent Recognition Agent for Botulinum Neurotoxin Subtype A. Journal of Medicinal Chemistry 56:7, pages 2791-2803.
Crossref
Seyed M. Jazayeri, Alireza Ashraf, Habib M. Fini, Hajar Karimian & Mohamadreza V. Nasab. (2011) Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain. Anesthesiology and Pain Medicine 1:2, pages 77-80.
Crossref
Mark Stacy & Joseph Jankovic. 2011. Parkinson's Disease. Parkinson's Disease 394 408 .
B. Rawicki, G. Sheean, V. S. C. Fung, S. Goldsmith, C. Morgan & I. Novak. (2010) Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement. European Journal of Neurology 17, pages 122-134.
Crossref
Teri R. Thomsen & Robert L. Rodnitzky. (2010) Juvenile Parkinsonism. CNS Drugs 24:6, pages 467-477.
Crossref
Frank J. Lebeda, Regina Z. Cer, Uma Mudunuri, Robert Stephens, Bal Ram Singh & Michael Adler. (2010) The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins. Toxins 2:5, pages 978-997.
Crossref
George M. Brenner & Craig W. Stevens. 2010. Pharmacology. Pharmacology 50 57 .
J. Jankovic. 2010. Encyclopedia of Movement Disorders. Encyclopedia of Movement Disorders 144 150 .
Giovanni Mostile & Joseph Jankovic. (2009) Treatment of dysautonomia associated with Parkinson's disease. Parkinsonism & Related Disorders 15, pages S224-S232.
Crossref
Joseph Jankovic. (2009) Disease-oriented approach to botulinum toxin use. Toxicon 54:5, pages 614-623.
Crossref
Marc Bachlin, Daniel Roggen, Gerhard Troster, Meir Plotnik, Noit Inbar, Inbal Meidan, Talia Herman, Marina Brozgol, Eliya Shaviv, Nir Giladi & Jeffrey M. Hausdorff. (2009) Potentials of Enhanced Context Awareness in Wearable Assistants for Parkinson's Disease Patients with the Freezing of Gait Syndrome. Potentials of Enhanced Context Awareness in Wearable Assistants for Parkinson's Disease Patients with the Freezing of Gait Syndrome.
Peter B. Arnold, Chris A. Campbell, George Rodeheaver, Wyndell Merritt, Raymond F. Morgan & David B. Drake. (2009) Modification of Blood Vessel Diameter following Perivascular Application of Botulinum Toxin-A. HAND 4:3, pages 302-307.
Crossref
Mark Stacy. (2009) Medical Treatment of Parkinson Disease. Neurologic Clinics 27:3, pages 605-631.
Crossref
James Keir & Henk P Giele. (2009) Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy. Hand Therapy 14:2, pages 32-38.
Crossref
Peter B. Arnold, Wyndell Merritt, George T. Rodeheaver, Chris A. Campbell, Raymond F. Morgan & David B. Drake. (2009) Effects of Perivascular Botulinum Toxin-A Application on Vascular Smooth Muscle and Flap Viability in the Rat. Annals of Plastic Surgery 62:5, pages 463-467.
Crossref
Mark Hallett. 2009. Botulinum Toxin. Botulinum Toxin 367 373 .
David M. Simpson & Yuen T. So. 2009. Botulinum Toxin. Botulinum Toxin 360 366 .
Barbara Illowsky Karp. 2009. Botulinum Toxin. Botulinum Toxin 102 111 .
Beatriz Arbaizar, Inés Gómez-Acebo & Javier Llorca. (2008) Postural induced-tremor in psychiatry. Psychiatry and Clinical Neurosciences 62:6, pages 638-645.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.